Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.2.759

Genistein Reinforces the Inhibitory Effect of Cisplatin on Liver Cancer Recurrence and Metastasis after Curative Hepatectomy  

Chen, Peng (Department of Liver Surgery, West China Hospital of Sichuan University)
Hu, Ming-Dao (Department of Hepato-biliary Surgery, the 2nd Affiliated Hospital of Kunming Medical College)
Deng, Xiao-Fan (Department of Liver Surgery, West China Hospital of Sichuan University)
Li, Bo (Department of Liver Surgery, West China Hospital of Sichuan University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.2, 2013 , pp. 759-764 More about this Journal
Abstract
Background: The high recurrence rate after hepatic resection in hepatocellular carcinoma (HCC) is a major obstacle to improving prognosis. The objective of the present study was to explore the function of genistein, a soy-derived isoflavone, in enhancing the inhibitory effect of cisplatin on HCC cell proliferation and on tumor recurrence and metastasis in nude mice after curative hepatectomy. Methods: Proliferation of human HCC cells (HCCLM3) was detected by 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) assay. Synergistic effects of genistein and cisplatin were evaluated with the median-effect formula. Nude mice bearing human HCC xenografts underwent tumour resection (hepatectomy) 10 days post implantation, then received intraperitoneal administration of genistein or cisplatin alone or the combination of the two drugs. 33 days after surgery, recurrent tumours and pulmonary metastasis were evaluated individually. MMP-2 level in recurrent tumours was detected by immunohistochemistry and real-time PCR; MMP-2 expression in HCCLM3 was detected by immunocytochemistry. Results: Genistein and cisplatin both suppressed the growth and proliferation of HCCLM3 cells. The two drugs exhibited synergistic effects even at relatively low concentrations. In vivo, mice in the combined genistein and cisplatin group had a smaller volume of liver recurrent tumors and fewer pulmonary metastatic foci compared with single drug treated groups. Cisplatin upregulated the expression of MMP-2 in both recurrent tumours and HCCLM3, while genistein abolished cisplatin-induced MMP-2 expression. Conclusions: Genistein reinforced the inhibitory effect of cisplatin on HCC cell proliferation and tumour recurrence and metastasis after curative hepatectomy in nude mice, possibly through mitigation of cisplatin-induced MMP-2 upregulation.
Keywords
Hepatocellular carcinoma; genistein; cisplatin; recurrent; metastasis;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Alisi A, Balsano C (2007). Enhancing the efficacy of hepatocellular carcinoma chemotherapeutics with natural anticancer agents. Nutr Rev, 65, 550-3.   DOI   ScienceOn
2 Banerjee S, Li Y, Wang Z, et al (2008). Multi-targeted therapy of cancer by genistein. Cancer Lett, 269, 226-42.   DOI   ScienceOn
3 Bosch FX, Ribes J, Diaz M, et al (2004). Primary liver cancer: worldwide incidence and trends. Gastroenterology, 127, S5-16.   DOI   ScienceOn
4 Chou TC, Talalay P (1984). Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul, 22, 27-55.   DOI   ScienceOn
5 Cohen JH, Kristal AR, Stanford JL (2000). Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst, 5, 61-8.
6 D'Anna R, Cannata ML, Atteritano M, et al (2007). Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study. Menopause, 14, 648-55.   DOI   ScienceOn
7 De Larco JE, Wueatz BR, Manivel JC, et al (2001). Progression and enhancement of metastatic potential after exposure of tumor cells to chemotherapeutic agents. Cancer Res, 1, 2857-61.
8 Giannelli G, Bergamini C, Marinosci F, et al (2002). Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma. Int J Cancer, 97, 425-31.   DOI   ScienceOn
9 Gurib-Fakim A (2006). Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Asp Med, 1, 1-93.
10 Gu Y, Zhu CF, Dai YL, et al (2009). Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma. World J Gastroentero, 15, 4952-7.   DOI
11 Kumi-Diaka J, Merchant K, Haces A (2010). Genistein-selenium combination induces growth arrest in prostate cancer cells. J Med Food, 13, 842-50.   DOI   ScienceOn
12 Jian Z, Tang ZY, Jia F, et al (2003). Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial cell growth factor. Clin Cancer Res, 18, 6030-7.
13 Lakshman M, Xu L, Ananthanarayanan V, et al (2008). Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Res, 68, 2024-32.   DOI   ScienceOn
14 Lamartiniere CA (2002). Timing of exposure and mammary cancer risk. J Mammary Gland Biol Neoplasia, 7, 67-76.   DOI   ScienceOn
15 Latifi A, Abubaker K, Castrechini N (2011). Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile. Cell Biochem, 112, 2850-64   DOI   ScienceOn
16 Llovet JM, Burroughs A, Bruix J (2003). Hepatocellular carcinoma. Lancet, 362, 1907-17.   DOI   ScienceOn
17 Li Y, Ahmed F, Ali S, et al (2005). Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res, 65, 6934-42.   DOI   ScienceOn
18 Li Y, Tang Y, Ye L, et al (2003). Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol, 129, 43 -51.
19 Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-8.   DOI   ScienceOn
20 Parkin DM, Pisani P, Ferlay J (1999). Global cancer statistics. CA Cancer J Clin, 49, 33-64.   DOI   ScienceOn
21 Sarkar FH, Li Y (2003). Soy isoflavones and cancer prevention. Cancer Invest, 21, 744-57.   DOI   ScienceOn
22 Sun FX, Tang ZY, Lui KD, et al (1996). Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Int J Cancer, 66, 239-43.   DOI
23 Sherman M (2005). Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis, 25, 143-54.   DOI   ScienceOn
24 Tang ZY (2000). Surgery of hepatocellular carcinoma with special reference to studies on metastasis and recurrence. Gastroenterol Today, 4, 191-5.
25 Tang ZY, Yu YQ, Zhou XD, et al (1998). Progress and prospects in hepatocellular carcinoma surgery. Ann Chir, 52, 558-63.
26 Yamamoto J, Kosuge T, Takayama T, et al (1996). Recurrence of hepatocellular carcinoma after surgery. Br J Surg, 83, 1219-22.   DOI   ScienceOn
27 Vihinen P, Ala-aho R, Kahari VM (2005). Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets, 5, 203-20.   DOI   ScienceOn
28 Wang L, Wu WZ, Sun HC, et al (2003). Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice. J Gastrointest Surg, 7, 587-94.   DOI   ScienceOn
29 Xiao CL, Tao ZH, Guo L, et al (2011). Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice. BMC Cancer, 11, 150-61   DOI   ScienceOn
30 Yang JM, Xu Z, Wu H, et al (2003). Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res, 1, 420-7.
31 Yang R, Rescorla FJ, Reilly CR, et al (1992). A reproducible rat liver cancer model for experimental therapy: introducing a technique of intrahepatic tumor implantation. J Surg Res, 52, 193-8.   DOI   ScienceOn
32 Ye JZ, Miao ZG, Wu FX, et al (2012). Recurrence after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis. Asian Pac J Cancer Prev, 13, 1771-7.   DOI   ScienceOn
33 Yeh TC, Chiang PC, Li TK, et al (2007). Genistein induces apoptosis in human hepatocellular carcinomas via interaction of endoplasmic reticulum stress and mitochondrial insult. Biochem Pharmacol, 73, 782-92.   DOI   ScienceOn
34 Yin M, Dhir R, Parwani AV, et al (2007). Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma. Diagn Pathol, 2, 41-6.   DOI